FUNCTIONAL RECOVERY AND REHABILITATION POTENTIAL AFTER REMOVAL OF INTRACRANIAL MENINGIOMAS

Authors

  • Ravshanov Davron Mavlonovich
  • Mavlyanova Zilola Farhadovna
  • Ashurov Rustamjon Furkatovich

Keywords:

meningioma; Ki-67; CD34; invasion of the brain; Simpson resection; Karnofsky Performance Status; Functional Independence Measure; rehabilitation potential.

Abstract

Meningiomas account for 30-35% of primary intracranial tumors in adults and are 1.8-2 times more common in women. Most Grade I tumors grow slowly, but up to 25% of Grade II-III tumors show atypia, deep invasion, and a high risk of recurrence. The proliferative index of Ki-67 and the microvascular density of CD34 reliably reflect the aggressiveness of meningiomas, and the depth of invasion ≥ 3 mm and incomplete resection according to Simpson increase the risk of tumor return. However, the effect of these markers on functional recovery (ΔKPS, ΔFIM) after surgery has not been sufficiently studied, and there is no single prognostic model for rehabilitation potential yet. Materials and methods. The study included 124 patients (mean age 56 ± 12 years; 61% women) operated on intracranial meningiomas in the period 2019-2024. Functional status was assessed before surgery and after 3 months using the Karnofsky Performance Status (KPS) scale (Mor et al., 1984) [13] and the Functional Independence Measure (FIM) scale (Keith et al., 1987) [8]; in this case, the increments of ΔKPS and ΔFIM were calculated. The histological grade of the tumor was determined according to the 2021 WHO classification. Using immunohistochemistry according to the protocol of Baay et al. (2018) [1], the Ki-67 proliferation index was assessed, and according to the method of Zhou et al. (2018) [21] - microvascular density (CD34, vascular/HPF). The depth of invasion into the brain was measured microscopically: ≥ 3 mm was considered significant (Behling et al., 2021) [2]. The degree of radical removal was classified according to the Simpson I-V scale (EANO, Marosi et al., 2008) [12]. Multivariate logistic regression analysis was used to identify independent factors associated with high rehabilitation potential (ΔKPS ≥ 15 and ΔFIM ≥ 20).  <0,05. Outcomes. ΔKPS and ΔFIM were significantly dependent on tumor grade: the median increase in KPS was +18 at Grade I, +11 at Grade II, and +4 at Grade III (p < 0.001); ΔFIM - +25, +14 and +6, respectively (p < 0.001). High RP (ΔKPS ≥ 15 and ΔFIM ≥ 20) was achieved in 73% of patients Grade I, 34,5 % - Grade II и 10,1 % — Grade III (p < 0,001). Independent predictors of high RP were: Ki-67 < 4% (OR = 4.6; p = 0.001), CD34 < 12 vessels/HPF (OR = 2.9; p = 0.008), Simpson I-II resection (OR = 2,5; p = 0,027) and the absence of diffuse invasion(OR = 3,2; p = 0,005). Conclusion: Low Ki-67 and CD34 values, radical resection and the absence of deep invasion serve as reliable markers of high rehabilitation potential. Taking them into account will make it possible to personalize the postoperative rehabilitation plan and improve recovery indicators in patients with intracranial meningiomas.

References

Baay MF, Mörk A, Zimmerman D, et al. Immunohistochemistry for Ki-67 in CNS tumors: guidelines. Pathol Res Pract. 2018;214(3):353-360.

Behling F, Fodi C, Gepfner-Tuma I, et al. Brain invasion in meningiomas: a predictor of poor outcome? Acta Neuropathol. 2021;142(4):613-625.

Durand A, Froelich S, Le Rhun E, et al. WHO Grade II and III meningiomas: prognostic factors and therapeutic strategy. Neurochirurgie. 2017;63(4):244-252.

Goldbrunner R, Minniti G, Preusser M, et al. EANO guideline on the diagnosis and management of meningiomas. Lancet Oncol. 2016;17(9):e383-e391.

Granger CV, Hamilton BB, Linacre JM, Heinemann AW, Wright BD. Performance profiles of the functional independence measure. Am J Phys Med Rehabil. 1993;72(2):84–89.

Hou J, Feng J, Yuan T, et al. Prognostic role of Ki-67 in meningioma patients: a systematic review and meta-analysis. World Neurosurg. 2020;136:e203-e210.

Kaley TJ, Wen PY, Schiff D, et al. Management of recurrent meningiomas. J Neurooncol. 2014;117(3):471-477.

Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.

Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803-820.

Louis DN, Ohgaki H, Wiestler OD, et al., eds. WHO Classification of Tumours of the Central Nervous System. 5th ed. Lyon: IARC Press; 2021.

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2021;142(1):11-13.

Marosi C, Hassler M, Roessler K, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2008;9(11):1065–1074.

Khaydarova Dildora Kadirovna, Khodjyeva Dilbar Tadjiyevna, Bobokulov Gulmurod Dilmurodovich. Optimization Of Neuroprotective Therapy Of Ischemic Stroke In The Acute Period. European Journal of Molecular & Clinical Medicine. Volume 07, Issue 03, 2020. Р. 3720-3723

Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol. 2018;20(suppl_4):iv1-iv86.

DT Hodzhieva, SS Pulatov, DK Hajdarova Vse o gemorragicheskom insulte lic pozhilogo i starcheskogo vozrasta.[All about hemorrhagic stroke of elderly and elderly people] Nauka molodyh-Young Science. 2015. 87-96.

Sandow N, Maurer MH, Giese A, Gaunitz F. Comprehensive analysis of microRNA expression profiles in meningiomas reveals novel candidate diagnostic and prognostic biomarkers. Acta Neuropathol Commun. 2014;2:46.

WHO Classification of Tumours Editorial Board. Central Nervous System Tumours. 5th ed. Lyon: IARC Press; 2021.

Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307–314.

World Medical Association. Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310(20):2191-2194.

Zheng Y, Liu X, Zhang Y, et al. Prognostic value of Ki-67/MIB-1 expression in meningiomas: evidence from 14 studies. Cell Prolif. 2020;53(1):e12715.

Zhou H, Zhang M, Luo Q, et al. CD34 expression predicts recurrence in meningiomas. Clin Neurol Neurosurg. 2018;171:48-52

Published

2025-09-12